{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:57:13Z","timestamp":1787727433422,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.heliyon.2022.e10175","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:55:13Z","timestamp":1660560913000},"page":"e10175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3698-174X","authenticated-orcid":false,"given":"Shweta","family":"Ramkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5625-4876","authenticated-orcid":false,"given":"Preeti K.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib1","first-page":"5","article-title":"Androgenetic alopecia and current methods of treatment","volume":"14","author":"Bienov\u00e1","year":"2005","journal-title":"Acta Dermatovenerol. Alpina Pannonica Adriatica"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib2","first-page":"1","article-title":"A\u00a0case of hair regrowth in a patient with complete androgen insensitivity syndrome and female pattern hair loss","volume":"4","author":"Laino","year":"2020","journal-title":"J.\u00a0Clin. Cosmet. Dermatol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10175_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00403-019-01920-1","article-title":"Lactoferrin promotes hair growth in mice and increases dermal papilla cell proliferation through Erk\/Akt and Wnt signaling pathways","volume":"311","author":"Huang","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.heliyon.2022.e10175_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1381612826666200515133142","article-title":"Nano-lipidic carriers as a tool for drug targeting to the pilosebaceous units","volume":"26","author":"Ramkar","year":"2020","journal-title":"Curr. Pharmaceut. Des."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1208\/s12249-012-9888-y","article-title":"Design and in vitro evaluation of finasteride-loaded liquid crystalline nanoparticles for topical delivery","volume":"14","author":"Madheswaran","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10175_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.sxmr.2018.07.003","article-title":"Sexual problems of men with androgenic alopecia treated with 5-alpha reductase inhibitors","volume":"7","author":"Coskuner","year":"2019","journal-title":"Sexual Med. Rev."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e10175_bib7","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.24028","article-title":"Topical formulations containing finasteride . Part I: in vitro permeation\/penetration study and in vivo pharmacokinetics in hairless rat","volume":"103","author":"Monti","year":"2014","journal-title":"J.\u00a0Pharmaceut. Sci."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2022.e10175_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.05.041","article-title":"Enhancement of follicular delivery of finasteride by liposomes and niosomes. 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models","volume":"323","author":"Tabbakhian","year":"2006","journal-title":"Int. J. Pharmceut."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e10175_bib9","first-page":"1","article-title":"A\u00a0novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers","author":"Caserini","year":"2014","journal-title":"Int. J. Clin. Pharm. Ther."},{"key":"10.1016\/j.heliyon.2022.e10175_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10847-010-9898-x","article-title":"Physicochemical characterization of finasteride: PEG-6000 and finasteride: Kollidon K25 solid dispersions, and finasteride: \u03b2-cyclodextrin inclusion complexes","volume":"70","author":"Almeida","year":"2011","journal-title":"J.\u00a0Inclusion Phenom. Macrocycl. Chem."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e10175_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2174\/1567201813666160614120809","article-title":"Topical analgesic nanolipid vesicles formulation of capsaicinoids extract of Bhut Jolokia (Capsicum chinense Jacq): pharmacodynamic evaluation in rat models and acceptability studies in human volunteers","volume":"13","author":"Sarwa","year":"2016","journal-title":"Curr. Drug Deliv."},{"issue":"141","key":"10.1016\/j.heliyon.2022.e10175_bib12","first-page":"1","article-title":"Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations","volume":"22","author":"Subramaniam","year":"2020","journal-title":"J.\u00a0Nanoparticle Res."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e10175_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ad.2020.03.001","article-title":"Spironolactone in dermatology: uses in acne, Hidradenitis Suppurativa , female pattern hair loss, and Hirsutism","volume":"111","author":"Vargas-Mora","year":"2020","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"issue":"288","key":"10.1016\/j.heliyon.2022.e10175_bib14","first-page":"1","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: a review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2022.e10175_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejps.2016.03.015","article-title":"Transdermal film-loaded finasteride microplates to enhance drug skin permeation: two-step optimization study","volume":"88","author":"Ahmed","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.heliyon.2022.e10175_bib16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2147\/IJN.S296793","article-title":"Physicochemical characterization of finasteride nanosystem for enhanced topical delivery","volume":"16","author":"Irfan","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10175_bib17","first-page":"1","article-title":"Enhancement of dermal delivery of finasteride using microemulsion systems","volume":"9","author":"Soleymani","year":"2019","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e10175_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2174\/1567201815666180124112905","article-title":"Finasteride topical delivery systems for androgenetic alopecia","volume":"15","author":"Khan","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10175_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/21691401.2016.1167699","article-title":"Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box\u2013Behnken design approach","volume":"45","author":"Moghddam","year":"2017","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10175_bib20","first-page":"457","article-title":"Optimization of finasteride nano-emulsion preparation using chemometric approach","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.heliyon.2022.e10175_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chemphyslip.2007.04.009","article-title":"The influence of selected steroid hormones on the physicochemical behaviour of DPPC liposomes","volume":"148","author":"Biruss","year":"2007","journal-title":"Chem. Phys. Lipids"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10175_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5530\/ijper.52.4.67","article-title":"Design, development and characterization of nano structured lipid carrier for topical delivery of aceclofenac","volume":"52","author":"Sethuraman","year":"2018","journal-title":"Indian J. Pharmaceut. Educ. Res."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e10175_bib23","first-page":"8","article-title":"DOE, formulation, and optimization of Repaglinide nanostructured lipid carriers","volume":"8","author":"Swidan","year":"2018","journal-title":"J.\u00a0Appl. Pharmaceut. Sci."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2022.e10175_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"366","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2022.e10175_bib25","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.2147\/IJN.S215835","article-title":"Formulation and evaluation of nanostructured lipid carriers (NLCs) of 20 (S)-Protopanaxadiol (PPD) by Box-Behnken Design","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib26","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.2147\/IJN.S73010","article-title":"Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia","volume":"9","author":"Shamma","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10175_bib27","first-page":"150","article-title":"Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery","volume":"10","author":"Id","year":"2020","journal-title":"Tabriz Univ. Med. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e10175_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1208\/s12249-008-9124-y","article-title":"In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers","volume":"9","author":"Rao","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e10175_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17091440","article-title":"Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses","volume":"17","author":"Siafaka","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib30","first-page":"1","article-title":"Pharmaceutical microemulsion: formulation, characterization and drug deliveries across skin","volume":"6","author":"Kumar","year":"2014","journal-title":"Int. J. Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13197-017-2937-5","article-title":"Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification","volume":"55","author":"Akhoond Zardini","year":"2018","journal-title":"J.\u00a0Food Sci. Technol."},{"key":"10.1016\/j.heliyon.2022.e10175_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2015.07.013","article-title":"Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy","volume":"492","author":"Ferreira","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10175_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jssas.2016.01.007","article-title":"Fenugreek: a review on its nutraceutical properties and utilization in various food products","volume":"17","author":"Wani","year":"2018","journal-title":"J.\u00a0Saudi Soc. Agric. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e10175_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000475473","article-title":"Design of finasteride-loaded nanoparticles for potential treatment of alopecia","volume":"30","author":"Roque","year":"2017","journal-title":"Skin Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/21691401.2014.909822","article-title":"Nanostructured lipid carriers and their current application in targeted drug delivery","volume":"44","author":"Jaiswal","year":"2016","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e10175_bib36","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/1061186X.2018.1527337","article-title":"Liposome: composition, characterisation, preparation, and recent innovation in clinical applications","volume":"27","author":"Ahmed","year":"2019","journal-title":"J.\u00a0Drug Target."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e10175_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib38","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.2147\/IJN.S73010","article-title":"Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia","volume":"9","author":"Shamma","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heliyon.2022.e10175_bib39","series-title":"Investigation of Nanoparticulate Formulation Intended for Caffeine Delivery to Hair Follicles","first-page":"13","author":"Mardiyanto","year":"2013"},{"key":"10.1016\/j.heliyon.2022.e10175_bib40","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2147\/DDDT.S171888","article-title":"Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach","volume":"12","author":"Ahmed","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2022.e10175_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/IJN.S98080","article-title":"Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation","volume":"11","author":"Ahmed","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e10175_bib42","first-page":"1","article-title":"Preparation, characterization and evaluation of finasteride ethosomes","volume":"8","author":"Sujatha","year":"2016","journal-title":"Int. J. Drug Deliv. Technol."},{"issue":"February","key":"10.1016\/j.heliyon.2022.e10175_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actbio.2015.02.007","article-title":"Precise engineering of dapivirine-loaded nanoparticles for the development of anti-HIV vaginal microbicides","volume":"18","author":"Das Neves","year":"2015","journal-title":"Acta Biomater."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2022.e10175_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.heliyon.2022.e10175_bib45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2014.05.054","article-title":"Advances in lipid-based colloid systems as drug carrier for topic delivery","volume":"193","author":"Zhai","year":"2014","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.heliyon.2022.e10175_bib46","first-page":"515","article-title":"Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation","volume":"11","author":"Ahmed","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e10175_bib47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1208\/s12249-016-0519-x","article-title":"Preparation and characterization of minoxidil loaded nanostructured lipid carriers","volume":"18","author":"Wang","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e10175_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.53879\/id.49.05.p0047","article-title":"Enhancement of folicular delivery of finasteride in niosomal and proniosomal gel form for treating androgenetic alopecia","volume":"49","author":"Vimal","year":"2012","journal-title":"Indian Drugs"},{"key":"10.1016\/j.heliyon.2022.e10175_bib49","first-page":"1","article-title":"Transfollicular drug delivery: current perspectives","volume":"5","author":"Jain","year":"2016","journal-title":"Res. Rep. Transdermal Drug Deliv."},{"key":"10.1016\/j.heliyon.2022.e10175_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/10837450701481181","article-title":"Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation","volume":"12","author":"Kumar","year":"2007","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.heliyon.2022.e10175_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2015.12.010","article-title":"Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects","volume":"223","author":"Mathes","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e10175_bib52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A\u00a0novel phase inversion-based process for the preparation of lipid nanocarriers","volume":"19","author":"Heurtault","year":"2002","journal-title":"Pharmaceut. Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022014633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022014633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:14:18Z","timestamp":1772010858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022014633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2405844022014633"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10175","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finasteride-loaded nano-lipidic carriers for follicular drug delivery: preformulation screening and Box-Behnken experimental design for optimization of variables","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e10175"}}